By activating downstream oncogenic signaling networks such as PI3K/AKT, MAPK/ERK, and STAT3, HER2 overexpression remodels the tumor microenvironment and induces epithelial-mesenchymal transition (EMT), thereby promoting tumor invasion, metastasis, and treatment resistance. This evidence concerns the gene STAT3 and neoplasm.